propidium has been researched along with vorinostat in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, S; Choe, TB; Hong, SI; Jin, HO; Kim, ES; Lee, HC; Lee, SJ; Park, IC; Rhee, CH; Seo, SK; Woo, SH; Yoo, DH | 1 |
Liu, S; Lu, D; Qu, X; Wang, P; Ying, H; Zhang, Y; Zhou, X; Zhu, H | 1 |
Bots, M; Cullinane, C; Martin, BP; Newbold, A | 1 |
3 other study(ies) available for propidium and vorinostat
Article | Year |
---|---|
Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
Topics: Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Survival; Drug Synergism; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indicators and Reagents; Lung Neoplasms; Membrane Potential, Mitochondrial; Propidium; Sulindac; Tumor Cells, Cultured; Vorinostat | 2008 |
Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.
Topics: Acetylation; Active Transport, Cell Nucleus; Blotting, Western; Chromatin Immunoprecipitation; DNA Primers; Drug Synergism; Flow Cytometry; Gene Expression Regulation, Viral; Green Fluorescent Proteins; HEK293 Cells; Histone Deacetylase Inhibitors; Histones; HIV Long Terminal Repeat; HIV-1; Humans; Hydroxamic Acids; Immunohistochemistry; Jurkat Cells; Microscopy, Fluorescence; NF-kappa B; Phorbol Esters; Propidium; Virus Latency; Vorinostat | 2012 |
Detection of apoptotic cells using propidium iodide staining.
Topics: Animals; Apoptosis; DNA; Flow Cytometry; Histone Deacetylase Inhibitors; Hydroxamic Acids; Lymphoma, B-Cell; Mice; Propidium; Staining and Labeling; Vorinostat | 2014 |